Sex and gender differences in the treatment of arterial hypertension
J Tamargo, R Caballero… - Expert review of clinical …, 2023 - Taylor & Francis
Introduction Arterial hypertension represents the leading modifiable risk factor for all-cause
death and early development of cardiovascular disease in women. Current clinical …
death and early development of cardiovascular disease in women. Current clinical …
Sex Differences in Cardiovascular Management: A Call for Better Acknowledgment—Part 1 Pharmacological Differences in Women and Men; How Relevant Are They …
AC Ivanescu, GA Dan - American Journal of Therapeutics, 2024 - journals.lww.com
Background: Sex differences (SDs) in pharmacology of cardiovascular (CV) drugs have
been described previously; however, paradoxically, there are scarce recommendations in …
been described previously; however, paradoxically, there are scarce recommendations in …
[HTML][HTML] Design of Experimental Approach for Development of Rapid High Performance Liquid Chromatographic Process for Simultaneous Estimation of Metoprolol …
M Attimarad, MJ Alali, HA Alali, DH Alabdulmuhsin… - Molecules, 2024 - mdpi.com
The design of an experimental approach, the Box–Behnken design, was implemented to
optimize the chromatographic condition to develop a rapid HPLC procedure for …
optimize the chromatographic condition to develop a rapid HPLC procedure for …
Italian Association of Hospital Cardiologists Position Paper 'Gender discrepancy: time to implement gender-based clinical management'
F Lucà, D Pavan, MM Gulizia, MT Manes… - European Heart …, 2024 - academic.oup.com
It has been well assessed that women have been widely under-represented in
cardiovascular clinical trials. Moreover, a significant discrepancy in pharmacological and …
cardiovascular clinical trials. Moreover, a significant discrepancy in pharmacological and …
Females present higher dose‐adjusted drug concentrations of metoprolol and allopurinol/oxypurinol than males
J Hindi, MO Pilon, M Meloche, G Leclair… - Clinical and …, 2023 - Wiley Online Library
Females present a higher risk of adverse drug reactions. Sex‐related differences in drug
concentrations may contribute to these observations but they remain understudied given the …
concentrations may contribute to these observations but they remain understudied given the …
[PDF][PDF] 左心疾病相关肺动脉高压患者的心律失常患病率及相关因素
刘创星， 孟哲， 邢钰， 李铭瑄， 辜和平 - 临床心血管病杂志, 2023 - lcxxg.whuhzzs.com
目的: 分析左心疾病相关肺动脉高压(PH-LHD) 患者不同类型心律失常的患病率及相关因素.
方法: 连续收集2021 年1 月—2021 年2 月于我院住院的PH-LHD 患者共500 例 …
方法: 连续收集2021 年1 月—2021 年2 月于我院住院的PH-LHD 患者共500 例 …
[HTML][HTML] Prevalence and related factors of arrhythmia in patients with left heart disease-related pulmonary hypertension
LIU Chuangxing, M Zhe, X Yu, LI Mingxuan… - J Clin …, 2023 - en.whuhzzs.com
Prevalence and related factors of arrhythmia in patients with left heart disease-related
pulmonary hypertension Homepage Journals 1.{{journal.titleEn}} {{journal.titleEn}} {{journal.titleEn}} …
pulmonary hypertension Homepage Journals 1.{{journal.titleEn}} {{journal.titleEn}} {{journal.titleEn}} …